AZ wins EU blessing for constipation drug Moventig
This article was originally published in Scrip
Executive Summary
AstraZeneca has gained European approval for its opioid-induced constipation (OIC) drug Moventig (naloxegol), the first peripherally-acting mu-opioid receptor antagonist (PAMORA) to be approved in Europe.